XML 61 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
Senior Notes, Secured, and Unsecured Indebtedness - Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Operating activities    
Net cash (used in) provided by operating activities $ (82,978) $ (220,354)
Investing activities    
Collection of related party note receivable 6,188 0
Investments in and advances to unconsolidated joint ventures   (1,000)
Purchases of property and equipment (773) (1,288)
Investments in subsidiaries 0 0
Net cash provided by (used in) investing activities 5,415 (2,288)
Financing activities    
Proceeds from borrowings on notes payable 111,992 84,926
Principal payments on notes payable (91,250) (21,123)
Proceeds from issuance of 7% senior notes 0 51,000
Proceeds from borrowings on Revolver 198,000 194,000
Payments on Revolver (167,000) (109,000)
Principal payments on subordinated amortizing notes (5,096) (4,999)
Payment of deferred loan costs (792) (1,755)
Proceeds from stock options exercised 0 106
Shares remitted to, or withheld by the Company for employee tax withholding (918) (1,826)
Purchase of common stock (918)  
Excess income tax benefit from stock based awards (238) 0
Noncontrolling interest contributions 36,140 13,125
Noncontrolling interest distributions (12,768) (8,204)
Advances to affiliates 0 0
Intercompany receivables/payables 0 0
Net cash provided by financing activities 68,070 196,250
Net decrease in cash and cash equivalents (9,493) (26,392)
Cash and cash equivalents — beginning of period 50,203 52,771
Cash and cash equivalents — end of period 40,710 26,379
Reporting Entities | Delaware Lyon    
Operating activities    
Net cash (used in) provided by operating activities (2,931) (3,108)
Investing activities    
Collection of related party note receivable 0  
Investments in and advances to unconsolidated joint ventures   0
Purchases of property and equipment 0 0
Investments in subsidiaries 0 0
Net cash provided by (used in) investing activities 0 0
Financing activities    
Proceeds from borrowings on notes payable 0 0
Principal payments on notes payable 0 0
Proceeds from issuance of 7% senior notes   0
Proceeds from borrowings on Revolver 0 0
Payments on Revolver 0 0
Principal payments on subordinated amortizing notes 0 0
Payment of deferred loan costs 0 0
Proceeds from stock options exercised   0
Shares remitted to, or withheld by the Company for employee tax withholding   0
Purchase of common stock 0  
Excess income tax benefit from stock based awards 0  
Noncontrolling interest contributions 0 0
Noncontrolling interest distributions 0 0
Advances to affiliates 0 0
Intercompany receivables/payables 2,931 3,108
Net cash provided by financing activities 2,931 3,108
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents — beginning of period 0 0
Cash and cash equivalents — end of period 0 0
Reporting Entities | California Lyon    
Operating activities    
Net cash (used in) provided by operating activities 18,174 (148,129)
Investing activities    
Collection of related party note receivable 6,188  
Investments in and advances to unconsolidated joint ventures   (1,000)
Purchases of property and equipment (809) (1,375)
Investments in subsidiaries (1,727) (6,572)
Net cash provided by (used in) investing activities 3,652 (8,947)
Financing activities    
Proceeds from borrowings on notes payable 2,211 30,415
Principal payments on notes payable (10,440) (8,725)
Proceeds from issuance of 7% senior notes   51,000
Proceeds from borrowings on Revolver 198,000 194,000
Payments on Revolver (167,000) (109,000)
Principal payments on subordinated amortizing notes (5,096) (4,999)
Payment of deferred loan costs (792) (1,755)
Proceeds from stock options exercised   106
Shares remitted to, or withheld by the Company for employee tax withholding   (1,826)
Purchase of common stock (918)  
Excess income tax benefit from stock based awards (238)  
Noncontrolling interest contributions 0 0
Noncontrolling interest distributions 0 0
Advances to affiliates 0 0
Intercompany receivables/payables (46,182) (21,706)
Net cash provided by financing activities (30,455) 127,510
Net decrease in cash and cash equivalents (8,629) (29,566)
Cash and cash equivalents — beginning of period 44,332 48,462
Cash and cash equivalents — end of period 35,703 18,896
Reporting Entities | Guarantor Subsidiaries    
Operating activities    
Net cash (used in) provided by operating activities (35,182) (19,212)
Investing activities    
Collection of related party note receivable 0  
Investments in and advances to unconsolidated joint ventures   0
Purchases of property and equipment 56 65
Investments in subsidiaries 46,801 27,885
Net cash provided by (used in) investing activities 46,857 27,950
Financing activities    
Proceeds from borrowings on notes payable 0 0
Principal payments on notes payable 0 (162)
Proceeds from issuance of 7% senior notes   0
Proceeds from borrowings on Revolver 0 0
Payments on Revolver 0 0
Principal payments on subordinated amortizing notes 0 0
Payment of deferred loan costs 0 0
Proceeds from stock options exercised   0
Shares remitted to, or withheld by the Company for employee tax withholding   0
Purchase of common stock 0  
Excess income tax benefit from stock based awards 0  
Noncontrolling interest contributions 0 0
Noncontrolling interest distributions 0 0
Advances to affiliates (4,479) (4,810)
Intercompany receivables/payables (9,391) (3,412)
Net cash provided by financing activities (13,870) (8,384)
Net decrease in cash and cash equivalents (2,195) 354
Cash and cash equivalents — beginning of period 2,723 573
Cash and cash equivalents — end of period 528 927
Reporting Entities | Non-Guarantor Subsidiaries    
Operating activities    
Net cash (used in) provided by operating activities (65,970) (52,390)
Investing activities    
Collection of related party note receivable 0  
Investments in and advances to unconsolidated joint ventures   0
Purchases of property and equipment (20) 22
Investments in subsidiaries 0 0
Net cash provided by (used in) investing activities (20) 22
Financing activities    
Proceeds from borrowings on notes payable 109,781 54,511
Principal payments on notes payable (80,810) (12,236)
Proceeds from issuance of 7% senior notes   0
Proceeds from borrowings on Revolver 0 0
Payments on Revolver 0 0
Principal payments on subordinated amortizing notes 0 0
Payment of deferred loan costs 0 0
Proceeds from stock options exercised   0
Shares remitted to, or withheld by the Company for employee tax withholding   0
Purchase of common stock 0  
Excess income tax benefit from stock based awards 0  
Noncontrolling interest contributions 36,140 13,125
Noncontrolling interest distributions (12,768) (8,204)
Advances to affiliates 11,056 9,327
Intercompany receivables/payables 3,922 (1,335)
Net cash provided by financing activities 67,321 55,188
Net decrease in cash and cash equivalents 1,331 2,820
Cash and cash equivalents — beginning of period 3,148 3,736
Cash and cash equivalents — end of period 4,479 6,556
Consolidation, Eliminations    
Operating activities    
Net cash (used in) provided by operating activities 2,931 2,485
Investing activities    
Collection of related party note receivable 0  
Investments in and advances to unconsolidated joint ventures   0
Purchases of property and equipment 0 0
Investments in subsidiaries (45,074) (21,313)
Net cash provided by (used in) investing activities (45,074) (21,313)
Financing activities    
Proceeds from borrowings on notes payable 0 0
Principal payments on notes payable 0 0
Proceeds from issuance of 7% senior notes   0
Proceeds from borrowings on Revolver 0 0
Payments on Revolver 0 0
Principal payments on subordinated amortizing notes 0 0
Payment of deferred loan costs 0 0
Proceeds from stock options exercised   0
Shares remitted to, or withheld by the Company for employee tax withholding   0
Purchase of common stock 0  
Excess income tax benefit from stock based awards 0  
Noncontrolling interest contributions 0 0
Noncontrolling interest distributions 0 0
Advances to affiliates (6,577) (4,517)
Intercompany receivables/payables 48,720 23,345
Net cash provided by financing activities 42,143 18,828
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents — beginning of period 0 0
Cash and cash equivalents — end of period $ 0 $ 0